Is saffron effective for managing peri‑menopausal symptoms, and what is the appropriate dosage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Saffron for Perimenopausal Symptoms

Saffron extract at 28 mg daily (14 mg twice daily) is effective for managing psychological symptoms of perimenopause, particularly anxiety and depression, but established guidelines do not include it as a recommended treatment option.

Guideline-Based Framework

The Endocrine Society 1 and AACE 2 clinical practice guidelines establish menopausal hormone therapy (MHT) as the most effective treatment for bothersome vasomotor and vaginal symptoms. These guidelines do not mention saffron or other herbal supplements as recommended interventions. The guidelines emphasize:

  • First-line treatment: MHT for women <60 years or within 10 years of menopause onset without contraindications 1
  • Non-hormonal alternatives: Clonidine, SSRIs, and gabapentin may be considered for women who cannot or will not use MHT 2
  • Individualized approach: Treatment selection based on symptom profile, contraindications, and patient preference 1, 2

Evidence for Saffron Efficacy

Psychological Symptoms (Strongest Evidence)

The highest quality recent evidence demonstrates saffron's effectiveness specifically for mood and psychological symptoms:

  • The 2021 RCT 3 using affron® (14 mg twice daily for 12 weeks) showed a 33% reduction in anxiety and 32% reduction in depression scores, with significant improvements in Greene Climacteric Scale psychological scores (p=0.032) and negative affect (p=0.043)

  • The 2018 study 4 demonstrated efficacy for both hot flashes and depressive symptoms using 30 mg/day (15 mg twice daily) for 6 weeks in postmenopausal women

  • The 2026 trial 5 confirmed improvements in depressive symptoms (48.8% achieving clinically meaningful improvement vs 25.6% placebo, p=0.026) and self-esteem with 28 mg/day

Vasomotor Symptoms (Limited Evidence)

The evidence for hot flashes is mixed:

  • One study 4 showed improvement in hot flash interference
  • However, the 2021 trial 3 found no significant improvement in vasomotor symptoms compared to placebo
  • A mixed herbal formula containing saffron 6 showed benefits, but cannot isolate saffron's specific contribution

Somatic and Other Symptoms

Saffron did not demonstrate significant improvements in somatic symptoms or most quality of life measures beyond psychological domains 3

Recommended Dosing Protocol

Based on the strongest evidence 3, 5:

  • Dose: 28 mg daily, administered as 14 mg twice daily
  • Formulation: Standardized saffron extract (affron® was used in the highest quality studies)
  • Duration: Minimum 12 weeks for full effect, though some benefits may appear by 6 weeks
  • Safety profile: Well-tolerated with no serious adverse events reported across trials

Clinical Decision Algorithm

For perimenopausal women with bothersome symptoms:

  1. Primary vasomotor symptoms (hot flashes, night sweats): MHT remains first-line per guidelines 1, 2; saffron has inconsistent evidence for these symptoms

  2. Primary psychological symptoms (anxiety, depression, mood disturbance): Saffron 28 mg daily is a reasonable option, particularly for women who:

    • Prefer non-hormonal treatment
    • Have contraindications to MHT
    • Experience predominantly mood symptoms rather than vasomotor symptoms

  3. Mixed symptom profile: Consider MHT as first-line per guidelines, with saffron as adjunctive therapy for residual mood symptoms or as alternative if MHT is declined/contraindicated

  4. Sleep disturbance: Evidence is mixed; saffron improved sleep-related impairment 5 but not sleep disturbance itself 3

Important Caveats

  • Guideline gap: Saffron is not included in established endocrine society guidelines 1, 2, reflecting its status as an emerging rather than established therapy
  • Symptom specificity: Benefits are primarily psychological; do not expect robust improvements in hot flashes or somatic symptoms based on current evidence
  • Quality matters: Studies used standardized extracts (affron®); efficacy of other saffron preparations is unknown
  • Not a replacement: For severe vasomotor symptoms, MHT remains more effective per guideline recommendations 1
  • Monitoring: Assess response at 6-8 weeks; if no improvement in psychological symptoms by 12 weeks, consider alternative approaches

The evidence supports saffron as a safe, well-tolerated option specifically for psychological symptoms of perimenopause, but it should not be positioned as equivalent to guideline-recommended MHT for comprehensive menopausal symptom management.

References

1
Guideline

treatment of symptoms of the menopause: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2015

2
Guideline

american association of clinical endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of menopause: executive summary of recommendations.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2011

Related Questions

Is saffron effective for managing female hormonal conditions such as premenstrual syndrome, and what dosage and safety precautions are recommended?
Is it safe for an adult taking Foundayo (orforglipron) for weight management to take 30 mg saffron extract for anxiety side effects?
Is it safe to take low-dose escitalopram (Lexapro) together with a saffron supplement?
What is the appropriate dosage of standardized saffron stigma extract for an adult with mild-to-moderate depression who is not taking prescription antidepressants?
Can a child safely take the herbal supplement Mood‑Mistic‑Saphron together with Prozac (fluoxetine)?
Is saffron effective for managing female hormonal conditions such as premenstrual syndrome, and what dosage and safety precautions are recommended?
How should a first seizure in a 3-year-old child without fever be managed?
What are the criteria for de‑escalating intravenous clindamycin to oral therapy in a patient with peritonsillar cellulitis?
What protein intake is recommended for a 24-year-old male with end-stage renal disease receiving dialysis three times per week?
What is the recommended management for opioid‑induced hyperalgesia?
What rescue medication and dose should be used for a 3-year-old child experiencing a seizure?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.